PATENT CLAIM ANALYSIS

Application Number: 15757285
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "489000"]

Abstract:
The invention relates to medicine and concerns a method for the poly signal activation of apoptosis of malignant solid tumour cells, carried out by means of the targeted delivery of thallium salts by surface-modified MS2 phage virions which contain a cyclic iRGD ligand that has a high affinity for the integrins avb3 and avb5 and is covalently bound with the shell and with the core, which contains genomic RNA and thallium salts. The invention provides for complex, efficient, prolonged cytotoxic action on focal and metastatic clusters of malignant solid tumour cells, while minimizing undesirable side effects on the healthy cells of an organism.

Claim (Index 9):
The method according to  claim 6 , wherein the apoptosis is used to diagnose malignant solid tumors.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 90.0
- Lexical Diversity: 1.50685
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11895198', '11850942', '11754761', '13946562', '12621416']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6551699037075075
- 35 USC 102 Novelty (BERT): 0.4907923681526911
- Combined Prediction Score: 0.6387321501520259
- Mean Citation Score: 152.887588
- Max Citation Score: 168.23082
- Similarity Product: 115.9521889410567

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test